News

Press Releases Events Presentations

2023 Inno Fire Awards, Top Funding Rounds: Novasenta

Pharmtech Focus: Novasenta Completes $40 million Series A to Advance Novel Cancer Therapeutics

Fierce Biotech Fundraising Tracker

Pittsburgh Inno: Novasenta raises $40M in Series A financing

Labiotech.eu: Biotech startup Novasenta raises $40M to advance novel cancer therapeutics

Endpoints Exclusive: UPMC launches another biotech, rooted in the tumor microenvironment

Next Pittsburgh: UPMC Enterprises invests $20 million in startup changing the way we fight cancer

Pittsburgh Business Times: UPMC launches cancer drug development firm Novasenta

Science Advisory Board: UPMC Launches Immunotherapy Company, Novasenta

MedCity News: UPMC launches cancer drug discovery company